Columbia University Medical Center- New York Presbyterian Onc Dept. is a clinical research site located in New York, New York, United States 10032.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Columbia University Medical Center- New York Presbyterian Onc Dept. has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: Locally Advanced or Metastatic NRAS Mutant Melanoma, Advanced Malignancies That Harbor IDHR132 Mutations.
Sponsors: Pfizer, Novartis Pharmaceuticals.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Columbia University Medical Center- New York Presbyterian Onc Dept. has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Columbia University Medical Center- New York Presbyterian Onc Dept. has 2 clinical trials on record, with 1 currently active. Their work covers Locally Advanced or Metastatic NRAS Mutant Melanoma, Advanced Malignancies That Harbor IDHR132 Mutations.
Columbia University Medical Center- New York Presbyterian Onc Dept. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.